{"created_at": "Fri Sep 14 19:43:24 +0000 2018", "id": 1040687478632411136, "id_str": "1040687478632411136", "text": "Congratulations to the finalists for the upcoming #Ophthalmology Innovator Awards at #OISX including our Chairman o\u2026 https://t.co/MCIcY5VCfk", "truncated": true, "entities": {"hashtags": [{"text": "Ophthalmology", "indices": [50, 64]}, {"text": "OISX", "indices": [85, 90]}], "symbols": [], "user_mentions": [], "urls": [{"url": "https://t.co/MCIcY5VCfk", "expanded_url": "https://twitter.com/i/web/status/1040687478632411136", "display_url": "twitter.com/i/web/status/1\u2026", "indices": [117, 140]}]}, "source": "<a href=\"http://twitter.com\" rel=\"nofollow\">Twitter Web Client</a>", "in_reply_to_status_id": null, "in_reply_to_status_id_str": null, "in_reply_to_user_id": null, "in_reply_to_user_id_str": null, "in_reply_to_screen_name": null, "user": {"id": 1004864618768916480, "id_str": "1004864618768916480", "name": "Oyster Point Pharma", "screen_name": "OysterPointRx", "location": "Princeton, NJ", "description": "Oyster Point is a commercial-stage pharmaceutical company developing innovative therapies to treat #DryEyeDisease. #DryEye #Ophthalmology #Optometry #EyeHealth", "url": "https://t.co/gSkX5DssTP", "entities": {"url": {"urls": [{"url": "https://t.co/gSkX5DssTP", "expanded_url": "https://oysterpointrx.com/", "display_url": "oysterpointrx.com", "indices": [0, 23]}]}, "description": {"urls": []}}, "protected": false, "followers_count": 438, "friends_count": 95, "listed_count": 0, "created_at": "Thu Jun 07 23:16:09 +0000 2018", "favourites_count": 9, "utc_offset": null, "time_zone": null, "geo_enabled": true, "verified": false, "statuses_count": 214, "lang": null, "contributors_enabled": false, "is_translator": false, "is_translation_enabled": false, "profile_background_color": "000000", "profile_background_image_url": "http://abs.twimg.com/images/themes/theme1/bg.png", "profile_background_image_url_https": "https://abs.twimg.com/images/themes/theme1/bg.png", "profile_background_tile": false, "profile_image_url": "http://pbs.twimg.com/profile_images/1155563508961988608/22523Ne0_normal.jpg", "profile_image_url_https": "https://pbs.twimg.com/profile_images/1155563508961988608/22523Ne0_normal.jpg", "profile_banner_url": "https://pbs.twimg.com/profile_banners/1004864618768916480/1570217375", "profile_link_color": "232F6E", "profile_sidebar_border_color": "000000", "profile_sidebar_fill_color": "000000", "profile_text_color": "000000", "profile_use_background_image": false, "has_extended_profile": false, "default_profile": false, "default_profile_image": false, "following": null, "follow_request_sent": null, "notifications": null, "translator_type": "none", "withheld_in_countries": []}, "geo": null, "coordinates": null, "place": null, "contributors": null, "is_quote_status": true, "quoted_status_id": 1040348176631439361, "quoted_status_id_str": "1040348176631439361", "quoted_status": {"created_at": "Thu Sep 13 21:15:08 +0000 2018", "id": 1040348176631439361, "id_str": "1040348176631439361", "text": "Here are the finalists for the upcoming Ophthalmology Innovator Awards at OIS X. https://t.co/uz7JNyL6F6  Now it's\u2026 https://t.co/A27vblVpcd", "truncated": true, "entities": {"hashtags": [], "symbols": [], "user_mentions": [], "urls": [{"url": "https://t.co/uz7JNyL6F6", "expanded_url": "https://buff.ly/2QsmR6E", "display_url": "buff.ly/2QsmR6E", "indices": [81, 104]}, {"url": "https://t.co/A27vblVpcd", "expanded_url": "https://twitter.com/i/web/status/1040348176631439361", "display_url": "twitter.com/i/web/status/1\u2026", "indices": [116, 139]}]}, "source": "<a href=\"https://buffer.com\" rel=\"nofollow\">Buffer</a>", "in_reply_to_status_id": null, "in_reply_to_status_id_str": null, "in_reply_to_user_id": null, "in_reply_to_user_id_str": null, "in_reply_to_screen_name": null, "user": {"id": 246888739, "id_str": "246888739", "name": "Ophthalmology Innovation Source", "screen_name": "OISTWEETS", "location": "New York, USA", "description": "Largest & Original Producer of World-Class Ophthalmology Innovation Conferences & Content Since 2009.", "url": "https://t.co/bQKvBCFvyQ", "entities": {"url": {"urls": [{"url": "https://t.co/bQKvBCFvyQ", "expanded_url": "https://ois.net", "display_url": "ois.net", "indices": [0, 23]}]}, "description": {"urls": []}}, "protected": false, "followers_count": 8597, "friends_count": 1550, "listed_count": 111, "created_at": "Thu Feb 03 17:33:43 +0000 2011", "favourites_count": 614, "utc_offset": null, "time_zone": null, "geo_enabled": false, "verified": false, "statuses_count": 3945, "lang": null, "contributors_enabled": false, "is_translator": false, "is_translation_enabled": false, "profile_background_color": "FFFFFF", "profile_background_image_url": "http://abs.twimg.com/images/themes/theme1/bg.png", "profile_background_image_url_https": "https://abs.twimg.com/images/themes/theme1/bg.png", "profile_background_tile": false, "profile_image_url": "http://pbs.twimg.com/profile_images/1164226821606584320/Fv0wsF1m_normal.jpg", "profile_image_url_https": "https://pbs.twimg.com/profile_images/1164226821606584320/Fv0wsF1m_normal.jpg", "profile_banner_url": "https://pbs.twimg.com/profile_banners/246888739/1639459427", "profile_link_color": "317AC6", "profile_sidebar_border_color": "000000", "profile_sidebar_fill_color": "DDEEF6", "profile_text_color": "333333", "profile_use_background_image": true, "has_extended_profile": true, "default_profile": false, "default_profile_image": false, "following": null, "follow_request_sent": null, "notifications": null, "translator_type": "none", "withheld_in_countries": []}, "geo": null, "coordinates": null, "place": null, "contributors": null, "is_quote_status": false, "retweet_count": 0, "favorite_count": 0, "favorited": false, "retweeted": false, "possibly_sensitive": false, "lang": "en"}, "retweet_count": 2, "favorite_count": 9, "favorited": false, "retweeted": false, "possibly_sensitive": false, "lang": "en"}